Deficient G2-M and S checkpoints are associated with increased lung cancer risk: A case-control analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 7, 2007, Pages 1517-1522

  Xing, Jinliang ^a   Spitz, Margaret R ^a   Lu, Charles ^a   Zhao, Hua ^a   Yang, Hushan ^a   Wang, Wei ^a   Stewart, David J ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTENUATION; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL HETEROGENEITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GAMMA RADIATION; HISTOLOGY; HUMAN; IONIZING RADIATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION EXPOSURE; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPHOCYTE; MIDDLE AGED; PHYSIOLOGY; RADIATION RESPONSE; RISK FACTOR;

CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; G2 PHASE; GAMMA RAYS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; RISK FACTORS; S PHASE;

EID: 34447550295     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0111     Document Type: Article

References (36)

1. Norbury CJ, Hickson ID. Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 2001;41:367-401.
2. Shackelford RE, Kaufmann WK, Paules RS. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 1999;107 Suppl 1:5-24.
3. O'Connor PM, Fan S. DNA damage checkpoints: implications for cancer therapy. Prog Cell Cycle Res 1996;2:165-73.
4. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003;22:5834-47.
5. Ishikawa K, Ishii H, Saito T. DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol 2006;25:406-11.
6. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 1994;31:1-13.
7. Murnane JP. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective. Cancer Metastasis Rev 1995;14:17-29.
8. Fournier C, Taucher-Scholz G. Radiation induced cell cycle arrest: an overview of specific effects following high-LET exposure. Radiother Oncol 2004;73 Suppl 2:S119-22.
9. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23.
10. Liu MC, Gelmann EP. P53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol 2002;29:246-57.
11. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000;33:261-74.
12. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996;92:130-4.
13. Hosokawa Y, Arnold A. Cyclin D1/PRAD1 as a central target in oncogenesis. J Lab Clin Med 1996;127:246-52.
14. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-47.
15. Singhal S, Amin KM, Kruklitis R, et al. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol Ther 2003;2:291-8.
16. Sutter T, Dansranjavin T, Lubinski J, et al. Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma. Int J Colorectal Dis 2002;17:374-80.
17. Lopez-Beltran A, MacLennan GT, Montironi R. Cyclin E as molecular marker in the management of breast cancer: a review. Anal Quant Cytol Histol 2006;28:111-4.
18. Zhao H, Spitz MR, Tomlinson GE, Zhang H, Minna JD, Wu X. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res 2001;61:7819-24.
19. Wu X, Roth JA, Zhao H, et al. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 2005;65:349-57.
20. Zheng YL, Loffredo CA, Alberg AJ, et al. Less efficient G2-M checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res 2005;65:9566-73.
21. Hu JJ, Smith TR, Miller MS, Lohman K, Case LD. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 2002;39:208-15.
22. Zheng R, Dahlstrom KR, Wei Q, Sturgis EM. Gamma radiation-induced apoptosis, G2 delay, and the risk of salivary and thyroid carcinomas - a preliminary report. Head Neck 2004;26:612-8.
23. Kao GD, McKenna WG, Yen TJ. Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene 2001;20:3486-96.
24. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
25. Bernhard EJ, Maity A, Muschel RJ, McKenna WG. Effects of ionizing radiation on cell cycle progression. A review. Radiat Environ Biophys 1995;34:79-83.
26. Iliakis G. Cell cycle regulation in irradiated and nonirradiated cells. Semin Oncol 1997;24:602-15.
27. Vucic V, Isenovic ER, Adzic M, Ruzdijic S, Radojcic MB. Effects of gamma-radiation on cell growth, cycle arrest, death, and superoxide dismutase expression by DU 145 human prostate cancer cells. Braz J Med Biol Res 2006;39:227-36.
28. Scott D, Spreadborough AR, Roberts SA. Less G(2) arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity? Int J Radiat Biol 2003;79:405-11.
29. Olivieri G, Micheli A. Mitotic delay and repair in human lymphocytes. Mutat Res 1983;122:65-72.
30. Fang Y, Tsao CC, Goodman BK, et al. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. EMBO J 2004;23:3164-74.
31. Kim JH, Kim H, Lee KY, et al. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 2006;15:1181-6.
32. Kruger L, Demuth I, Neitzel H, et al. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis 2007;28:107-11.
33. Xu B, Kim S, Kastan MB. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001;21:3445-50.
34. Konishi H, Nakagawa T, Harano T, et al. Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3ε at 17p13.3 in small cell lung cancers. Cancer Res 2002;62:271-6.
35. Beamish H, Williams R, Chen P, Lavin MF. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J Biol Chem 1996;271:20486-93.
36. Girard PM, Riballo E, Begg AC, Waugh A, Jeggo PA. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 2002;21:4191-9.